Fluicell AB (OSTO:FLUI) FFO


OSTO:FLUI Fluicell AB OSTO:FLUI
54 GF Score
Price kr30.90
GF Value kr34.58
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fluicell AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:FLUI
54GF Score
Fluicell AB OSTO:FLUI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fluicell AB (OSTO:FLUI) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be undervalued. The current stock price of kr30.90 is trading 10.6% below its estimated GF Value™ of kr34.58. GuruFocus considers Fluicell AB to be Modestly Undervalued.

Key valuation signals for OSTO:FLUI:

  • FFO:
  • GF Value™: kr34.58 vs. price of kr30.90 (10.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:FLUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Other Exchanges 5J90:Germany
Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37
Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.
54GF Score

Get the complete analysis for OSTO:FLUI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr30.90
Price
kr34.58
GF Value